Cargando…

Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series

Primary familial brain calcification (PFBC) is a neurological condition characterized by the presence of intracranial calcifications, mainly involving basal ganglia, thalamus, and dentate nuclei. So far, six genes have been linked to this condition: SLC20A2, PDGFRB, PDGFB, and XPR1 inherited as auto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magistrelli, Luca, Croce, Roberta, De Marchi, Fabiola, Basagni, Chiara, Carecchio, Miryam, Nasuelli, Nicola, Cantello, Roberto, Invernizzi, Federica, Garavaglia, Barbara, Comi, Cristoforo, Mazzini, Letizia, D’Alfonso, Sandra, Corrado, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997821/ https://www.ncbi.nlm.nih.gov/pubmed/33471268 http://dx.doi.org/10.1007/s10048-021-00634-9

Ejemplares similares

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review
por: Lombardi, Michele, et al.
Publicado: (2023)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers
por: Tondo, Giacomo, et al.
Publicado: (2022)

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage
por: Carecchio, M., et al.
Publicado: (2014)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

The clinical and genetic spectrum of primary familial brain calcification
por: Carecchio, Miryam, et al.
Publicado: (2023)

Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment
por: De Marchi, Fabiola, et al.
Publicado: (2023)

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
por: Vignaroli, Francesca, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis progression in the year of the COVID-19 pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Accelerated Early Progression of Amyotrophic Lateral Sclerosis over the COVID-19 Pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series
por: Nasuelli, Nicola Alessandro, et al.
Publicado: (2020)

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
por: Fleetwood, Thomas, et al.
Publicado: (2018)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

Encephalopathies with intracranial calcification in children: clinical and genetic characterization
por: Tonduti, Davide, et al.
Publicado: (2018)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: a case report
por: Gramaglia, Carla, et al.
Publicado: (2014)

Detection of White Matter Ultrastructural Changes for Amyotrophic Lateral Sclerosis Characterization: A Diagnostic Study from Dti-Derived Data
por: De Marchi, Fabiola, et al.
Publicado: (2020)

MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism
por: Chelban, Viorica, et al.
Publicado: (2020)

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations
por: Ripellino, Paolo, et al.
Publicado: (2014)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients
por: De Marchi, Fabiola, et al.
Publicado: (2022)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy
por: Varrasi, Claudia, et al.
Publicado: (2022)

The prevention of falls in patients with Parkinson’s disease with in-home monitoring using a wearable system: a pilot study protocol
por: Campani, Daiana, et al.
Publicado: (2022)

Susac Syndrome: an uncommon cause of impaired vision
por: Barbero, Paolo, et al.
Publicado: (2022)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
por: Zhang, Yujie, et al.
Publicado: (2020)

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis
por: Virgilio, Eleonora, et al.
Publicado: (2023)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

N2OAS
por: Mulder, H
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_frvrnvvuu7gj36t0qhcqa33j74